AbCellera Biologics Newsroom

Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating

Futu NewsNov 7 22:35

Bloom Burton Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $9

Futu NewsNov 7 02:31

A Quick Look at Today's Ratings for AbCellera Biologics(ABCL.US), With a Forecast Between $7 to $12

Futu NewsNov 6 21:08

AbCellera Biologics Analyst Ratings

BenzingaNov 5 23:47

Benchmark Co. Maintains AbCellera Biologics(ABCL.US) With Hold Rating

Futu NewsNov 5 20:34

TD Cowen Initiates AbCellera Biologics(ABCL.US) With Buy Rating

Futu NewsNov 5 10:34

TD Cowen Remains a Buy on AbCellera Biologics (ABCL)

TipRanksNov 5 10:28

KeyBanc Maintains AbCellera Biologics(ABCL.US) With Buy Rating

Futu NewsAug 23 15:31

Benchmark Co. Downgrades AbCellera Biologics(ABCL.US) to Hold Rating

Futu NewsAug 20 19:33

Strong Liquidity and Strategic Alliances Underpin Buy Rating for AbCellera Biologics

TipRanksAug 9 18:04

Understanding the Buy Rating: A Synopsis of AbCellera Biologics' Investment Potential

TipRanksAug 8 21:53

TD Cowen Maintains AbCellera Biologics(ABCL.US) With Buy Rating

Futu NewsAug 7 11:32

TD Cowen Remains a Buy on AbCellera Biologics (ABCL)

TipRanksAug 7 10:57

KeyBanc Adjusts Price Target on AbCellera Biologics to $5 From $7, Maintains Overweight Rating

MT NewswiresJul 11 21:38

AbCellera Biologics Analyst Ratings

BenzingaJul 11 19:26

Keybanc Maintains Overweight on AbCellera Biologics, Lowers Price Target to $5

BenzingaJul 11 19:26

KeyBanc Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)

TipRanksMay 16 14:30

Analysts Offer Insights on Healthcare Companies: Certara (CERT), Exact Sciences (EXAS) and AbCellera Biologics (ABCL)

TipRanksMay 10 13:55

Keybanc: Maintaining the ABCellera Biologics (ABCL.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $8.00 to $7.00.

Zhitong FinanceMay 9 02:20

AbCellera Biologics Analyst Ratings

BenzingaMay 9 02:20